These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37921574)

  • 1. Impact of telemedicine on disease activity assessment: A case-crossover study nested within a cohort of patients with systemic lupus erythematosus.
    Almaghlouth I; Almalag HM; Alzuhair H; Alsaigh R; Bedaiwi A; Hassen LM; Alzomia S; Alanazi B; Alabdulkareem AM; Alahmari S; Asfina KN; Khalil N; Omair MA; Bedaiwi M
    Lupus; 2023 Dec; 32(14):1610-1618. PubMed ID: 37921574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR
    Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
    Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
    J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
    Urowitz MB; Gladman DD; Ibañez D; Fortin PR; Bae SC; Gordon C; Clarke A; Bernatsky S; Hanly JG; Isenberg D; Rahman A; Sanchez-Guerrero J; Wallace DJ; Ginzler E; Alarcón GS; Merrill JT; Bruce IN; Sturfelt G; Nived O; Steinsson K; Khamashta M; Petri M; Manzi S; Ramsey-Goldman R; Dooley MA; van Vollenhoven RF; Ramos M; Stoll T; Zoma A; Kalunian K; Aranow C
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):132-7. PubMed ID: 21954226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
    Gatto M; Saccon F; Zen M; Regola F; Fredi M; Andreoli L; Tincani A; Urban ML; Emmi G; Ceccarelli F; Conti F; Bortoluzzi A; Govoni M; Tani C; Mosca M; Ubiali T; Gerosa M; Bozzolo E; Canti V; Cardinaletti P; Gabrielli A; Tanti G; Gremese E; De Marchi G; De Vita S; Fasano S; Ciccia F; Pazzola G; Salvarani C; Negrini S; Puppo F; Di Matteo A; De Angelis R; Orsolini G; Rossini M; Faggioli P; Laria A; Piga M; Mathieu A; Scarpato S; Rossi FW; de Paulis A; Brunetta E; Ceribelli A; Selmi C; Prete M; Racanelli V; Vacca A; Bartoloni E; Gerli R; Larosa M; Iaccarino L; Doria A
    Arthritis Rheumatol; 2020 Aug; 72(8):1314-1324. PubMed ID: 32275125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic Cohort.
    Urowitz MB; Gladman DD; Ibañez D; Su J; Mursleen S; Sayani A; Ross Terres JA; Iczkovitz S
    J Rheumatol; 2021 Jan; 48(1):67-73. PubMed ID: 32238510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
    Medhat BM; Behiry ME; Sobhy N; Farag Y; Marzouk H; Mostafa N; Khalifa I; Elkhalifa M; Eissa BM; Hassan EHE
    Clin Rheumatol; 2020 Feb; 39(2):435-442. PubMed ID: 31758421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
    Lai NS; Lu MC; Chang HH; Lo HC; Hsu CW; Huang KY; Tung CH; Hsu BB; Wu CH; Koo M
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34063379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus Low Disease Activity State and Reduced Direct Health Care Costs in Patients With Systemic Lupus Erythematosus.
    Yeo AL; Koelmeyer R; Kandane-Rathnayake R; Golder V; Hoi A; Huq M; Hammond E; Nab H; Nikpour M; Morand EF
    Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1289-1295. PubMed ID: 31282076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients.
    Jesus D; Rodrigues M; Matos A; Henriques C; Pereira da Silva JA; Inês LS
    Lupus; 2019 Apr; 28(5):607-612. PubMed ID: 30895904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
    Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
    Aljohani R; Gladman DD; Su J; Urowitz MB
    Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
    Leosuthamas P; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
    Int J Rheum Dis; 2023 Apr; 26(4):667-672. PubMed ID: 36802112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L; Leone V; Pilkington C; Tullus K; Rangaraj S; McDonagh JE; Gardner-Medwin J; Wilkinson N; Riley P; Tizard J; Armon K; Sinha MD; Ioannou Y; Archer N; Bailey K; Davidson J; Baildam EM; Cleary G; McCann LJ; Beresford MW;
    Arthritis Rheum; 2012 Jul; 64(7):2356-65. PubMed ID: 22294381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
    Hanly JG; Urowitz MB; O'Keeffe AG; Gordon C; Bae SC; Sanchez-Guerrero J; Romero-Diaz J; Clarke AE; Bernatsky S; Wallace DJ; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Petri M; Fortin PR; Gladman DD; Fessler BJ; Alarcón GS; Bruce IN; Dooley MA; Steinsson K; Khamashta MA; Ramsey-Goldman R; Manzi S; Sturfelt GK; Nived O; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Aranow C; Mackay M; Ruiz-Irastorza G; Kalunian KC; Lim SS; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Theriault C; Thompson K; Farewell V
    Arthritis Rheum; 2013 Nov; 65(11):2887-97. PubMed ID: 24166793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.